CNE100002WP3
CNE100002WP3
NANJING KING-FRIEND BIOCHEMICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.990.678.037 | 3.923.585.844 | 1.7% |
| Cost of Revenue | 2.418.108.674 | 2.228.370.212 | 8.5% |
| Gross Profit | 1.572.569.363 | 1.695.215.631 | 7.2% |
| 991.202.317 | 780.014.191 | 27.1% | |
| Operating Income | 581.367.045 | 915.201.440 | 36.5% |
| Pretax Income | 699.416.367 | 992.033.745 | 29.5% |
| Net Income Common Stockholders | 581.536.154 | 826.144.870 | 29.6% |
| -- | -- | -- | |
| -- | -- | -- |